uniQure N.V. Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax
uniQure N.V. (QURE) reported Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax of $6.69 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-28.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax · last filed 2019-10-28
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2019-09-30 was $6.31M, a 695.21% increase year-over-year.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2019-06-30 was -$1.43M, a 143.64% decline year-over-year.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2019-03-31 was $1.82M, a 1289.31% increase year-over-year.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2018-12-31 was $1.29M.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2018 was $5.50M.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2017 was -$4.22M, a 659.21% decline from fiscal 2016.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2016 was $755.00K, a 43.54% increase from fiscal 2015.
- uniQure N.V. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2015 was $526.00K, a 89.03% decline from fiscal 2014.
| Period end | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month as first filed | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 6 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 9 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | $6.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $4.87M derived: sum of 2 quarters · filed 2019-10-28 | $6.69M 10-Q · filed 2019-10-28 | $7.98M derived: sum of 4 quarters · filed 2019-10-28 | |
| 2019-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $386.00K 10-Q · filed 2019-07-29 | $1.68M derived: sum of 3 quarters · filed 2019-07-29 | $2.47M derived: sum of 4 quarters · filed 2019-10-28 | |
| 2019-03-31 | $1.82M 10-Q · filed 2019-04-29 | $3.11M derived: sum of 2 quarters · filed 2019-04-29 | $3.90M derived: sum of 3 quarters · filed 2019-10-28 | $7.19M derived: sum of 4 quarters · filed 2019-10-28 | |
| 2018-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.08M derived: sum of 2 quarters · filed 2019-10-28 | $5.37M derived: sum of 3 quarters · filed 2019-10-28 | $5.50M 10-K · filed 2019-02-28 | |
| 2018-09-30 | $793.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $4.08M derived: sum of 2 quarters · filed 2019-10-28 | $4.21M 10-Q · filed 2019-10-28 | $1.81M derived: sum of 4 quarters · filed 2019-10-28 | |
| 2018-06-30 | $3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $3.42M 10-Q · filed 2019-07-29 | $1.02M derived: sum of 3 quarters · filed 2019-07-29 | $363.00K derived: sum of 4 quarters · filed 2019-07-29 | |
| 2018-03-31 | $131.00K 10-Q · filed 2019-04-29 | -$2.27M derived: sum of 2 quarters · filed 2019-04-29 | -$2.92M derived: sum of 3 quarters · filed 2019-04-29 | -$3.92M derived: sum of 4 quarters · filed 2019-04-29 | |
| 2017-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$3.05M derived: sum of 2 quarters · filed 2019-02-28 | -$4.05M derived: sum of 3 quarters · filed 2019-02-28 | -$4.22M 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.65M derived: sum of 2 quarters · filed 2018-11-06 | -$1.82M 10-Q · filed 2018-11-06 | $713.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | -$992.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.17M 10-Q · filed 2018-08-08 | $1.37M derived: sum of 3 quarters · filed 2019-02-28 | $890.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | -$176.00K 10-Q · filed 2018-04-30 | -$174.00K 10-Q · filed 2017-05-09 | $2.36M derived: sum of 2 quarters · filed 2019-02-28 | $1.88M derived: sum of 3 quarters · filed 2019-02-28 | $2.88M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.06M derived: sum of 2 quarters · filed 2019-02-28 | $3.06M derived: sum of 3 quarters · filed 2019-02-28 | $755.00K 10-K · filed 2019-02-28 | |
| 2016-09-30 | -$476.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $525.00K derived: sum of 2 quarters · filed 2017-11-01 | -$1.78M 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$1.30M 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | -$2.30M 10-Q · filed 2017-05-09 | ||||
| 2015-12-31 | $526.00K 10-K · filed 2018-03-14 | ||||
| 2014-12-31 | $4.80M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |